심폐 부하 검사 시스템 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Cardiopulmonary Stress Testing System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End user, By Region & Competition, 2020-2030F
심폐 부하 검사 시스템 세계 시장 규모는 2024년 51억 2,000만 달러로 평가되었고, 예측 기간인 2030년까지 연평균 6.11%의 괄목할 만한 성장이 예상됩니다.
세계 심폐 부하 검사 시스템 시장은 심혈관 및 호흡기 질환의 유병률 증가, 조기 진단의 중요성에 대한 인식 증가, 기술 발전, 고령화 인구 증가 등 다양한 요인으로 인해 최근 몇 년동안 큰 성장세를 보이고 있습니다. 심폐 부하 검사 시스템은 심장과 폐의 기능적 능력을 평가하는 데 중요한 역할을 하며, 의료진이 심장과 폐의 상태를 진단하고 관리하는 데 필수적인 도구가 되고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모(2024년) |
51억 2,000만 달러 |
| 시장 규모(2030년) |
72억 5,000만 달러 |
| CAGR(2025-2030년) |
6.11% |
| 급성장 부문 |
맥박 산소 측정기 |
| 최대 시장 |
북미 |
시장 성장 촉진요인
심혈관 및 호흡기 질환 증가로 세계 심폐 부하 검사 시스템 시장을 주도하고 있습니다.
주요 시장 이슈
높은 장비 및 유지보수 비용
주요 시장 동향
기술 발전
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 심폐 부하 검사 시스템 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 제품별(펄스옥시미터, 스트레스 혈압 모니터, 스트레스 심전도)
- 용도별(수술전 평가, 스포츠 스트레스 테스트)
- 최종사용자별(병원 및 진료소, 외래 진료 센터, 기타)
- 지역별
- 기업별(2024년 시장 주요 5개사 점유율)
- 시장 맵
제6장 북미의 심폐 부하 검사 시스템 시장 전망
제7장 유럽의 심폐 부하 검사 시스템 시장 전망
제8장 아시아태평양의 심폐 부하 검사 시스템 시장 전망
제9장 남미의 심폐 부하 검사 시스템 시장 전망
제10장 중동 및 아프리카의 심폐 부하 검사 시스템 시장 전망
제11장 시장 역학
제12장 시장 동향과 발전
제13장 경쟁 구도
- Koninklijke Philips NV.
- Hillrom Services Inc.
- General Electric Company
- MGC Diagnostics Corporation.
- OSI Systems Inc.
- Schiller AG
- NIHON KOHDEN CORPORATION
- Vyaire Medical, Inc.
- Halma plc(SunTech Medical, Inc.)
- Cosmed srl
제14장 전략적 제안
제15장 리서치사에 대해 & 면책사항
LSH
Global Cardiopulmonary Stress Testing System Market was valued at USD 5.12 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.11% through 2030. The global Cardiopulmonary Stress Testing System market has witnessed significant growth in recent years, driven by various factors such as the increasing prevalence of cardiovascular and respiratory diseases, rising awareness about the importance of early diagnosis, advancements in technology, and a growing aging population. Cardiopulmonary stress testing systems play a crucial role in assessing the functional capacity of the heart and lungs, making them vital tools for healthcare providers in diagnosing and managing cardiac and pulmonary conditions.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 5.12 Billion |
| Market Size 2030 | USD 7.25 Billion |
| CAGR 2025-2030 | 6.11% |
| Fastest Growing Segment | Pulse Oximeter |
| Largest Market | North America |
Key Market Drivers
Increasing cardiovascular and respiratory disorders is driving the Global Cardiopulmonary Stress Testing System Market
Cardiovascular and respiratory disorders pose a significant global health challenge, affecting millions of individuals and straining healthcare systems worldwide. These disorders, which include conditions such as heart disease, hypertension, asthma, and chronic obstructive pulmonary disease (COPD), can have severe consequences on an individual's health and quality of life. In response to this growing health concern, the global cardiopulmonary stress testing system market is experiencing rapid growth as healthcare providers seek innovative solutions for early diagnosis, monitoring, and management of these conditions. For instance, in 2025, Respiratory Pathology and Cardiovascular Diseases: A Scoping Review explores the connection between respiratory conditions and cardiovascular diseases, providing insights into their interplay and potential diagnostic or treatment advancements.
Key Market Challenges
High Cost of Equipment and Maintenance
One of the primary challenges in the cardiopulmonary stress testing system market is the high cost associated with both purchasing and maintaining the equipment. These systems are complex, incorporating advanced technologies like gas analyzers, electrocardiogram machines, and specialized software. Healthcare providers, particularly in low-resource settings, may find it financially burdensome to invest in these expensive systems. The ongoing maintenance and calibration requirements add to the overall cost of ownership, making it difficult for some facilities to sustain these technologies.
Key Market Trends
Technological Advancements
The Advancements in technology have permeated every aspect of our lives, including healthcare. In the realm of medical diagnostics, cardiopulmonary stress testing systems have witnessed a significant surge in demand and sophistication. These systems play a pivotal role in assessing a patient's cardiovascular and pulmonary health under stress conditions, helping healthcare professionals make more accurate diagnoses and treatment decisions. The global cardiopulmonary stress testing system market is experiencing robust growth, primarily fueled by innovations in technology and the growing prevalence of cardiovascular and pulmonary diseases.
One of the most notable technological advancements in this field is the integration of advanced sensors and wearables. These devices can continuously monitor a patient's heart rate, blood pressure, oxygen saturation, and respiratory parameters during exercise, providing real-time data for more precise assessments. This data can be analyzed instantly or remotely, enabling physicians to make timely decisions. AI and machine learning algorithms have made it possible to process and interpret the vast amount of data generated during cardiopulmonary stress tests more efficiently and accurately. AI-driven systems can detect subtle abnormalities in the data, allowing for early detection of cardiovascular and pulmonary disorders. The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring solutions. Cardiopulmonary stress testing systems are no exception. Patients can now perform stress tests at home or in remote locations while healthcare providers monitor their progress in real-time. This not only increases accessibility but also reduces the burden on healthcare facilities.
Key Market Players
- Koninklijke Philips NV
- Hillrom Services Inc.
- General Electric Company
- MGC Diagnostics Corporation.
- OSI Systems Inc.
- Schiller AG
- NIHON KOHDEN CORPORATION
- Vyaire Medical, Inc.
- Halma plc (SunTech Medical, Inc.)
- Cosmed srl
Report Scope:
In this report, the Global Cardiopulmonary Stress Testing System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cardiopulmonary Stress Testing System Market, By Product:
- Pulse Oximeter
- Stress Blood Pressure Monitor
- Stress ECG
Cardiopulmonary Stress Testing System Market, By Application:
- Preoperative Evaluation
- Stress Testing In Sport
Cardiopulmonary Stress Testing System Market, By End user:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
Cardiopulmonary Stress Testing System Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Cardiopulmonary Stress Testing System Market.
Available Customizations:
Global Cardiopulmonary Stress Testing System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validations
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cardiopulmonary Stress Testing System Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Product (Pulse Oximeter, Stress Blood Pressure Monitor, Stress ECG)
- 5.2.2. By Application (Preoperative Evaluation, Stress Testing In Sport)
- 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (Shares of Top 5 Market Players, 2024)
- 5.3. Market Map
- 5.3.1. By Product
- 5.3.2. By Application
- 5.3.3. By End user
- 5.3.4. By Region
6. North America Cardiopulmonary Stress Testing System Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By End user
- 6.2.4. By Country
- 6.2.4.1. United States Cardiopulmonary Stress Testing System Market Outlook
- 6.2.4.1.1. Market Size & Forecast
- 6.2.4.1.1.1. By Value
- 6.2.4.1.2. Market Share & Forecast
- 6.2.4.1.2.1. By Product
- 6.2.4.1.2.2. By Application
- 6.2.4.1.2.3. By End User
- 6.2.4.2. Canada Cardiopulmonary Stress Testing System Market Outlook
- 6.2.4.2.1. Market Size & Forecast
- 6.2.4.2.1.1. By Value
- 6.2.4.2.2. Market Share & Forecast
- 6.2.4.2.2.1. By Product
- 6.2.4.2.2.2. By Application
- 6.2.4.2.2.3. By End User
- 6.2.4.3. Mexico Cardiopulmonary Stress Testing System Market Outlook
- 6.2.4.3.1. Market Size & Forecast
- 6.2.4.3.1.1. By Value
- 6.2.4.3.2. Market Share & Forecast
- 6.2.4.3.2.1. By Product
- 6.2.4.3.2.2. By Application
- 6.2.4.3.2.3. By End User
7. Europe Cardiopulmonary Stress Testing System Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
- 7.2.4.1. France Cardiopulmonary Stress Testing System Market Outlook
- 7.2.4.1.1. Market Size & Forecast
- 7.2.4.1.1.1. By Value
- 7.2.4.1.2. Market Share & Forecast
- 7.2.4.1.2.1. By Product
- 7.2.4.1.2.2. By Application
- 7.2.4.1.2.3. By End User
- 7.2.4.2. Germany Cardiopulmonary Stress Testing System Market Outlook
- 7.2.4.2.1. Market Size & Forecast
- 7.2.4.2.1.1. By Value
- 7.2.4.2.2. Market Share & Forecast
- 7.2.4.2.2.1. By Product
- 7.2.4.2.2.2. By Application
- 7.2.4.2.2.3. By End User
- 7.2.4.3. United Kingdom Cardiopulmonary Stress Testing System Market Outlook
- 7.2.4.3.1. Market Size & Forecast
- 7.2.4.3.1.1. By Value
- 7.2.4.3.2. Market Share & Forecast
- 7.2.4.3.2.1. By Product
- 7.2.4.3.2.2. By Application
- 7.2.4.3.2.3. By End User
- 7.2.4.4. Italy Cardiopulmonary Stress Testing System Market Outlook
- 7.2.4.4.1. Market Size & Forecast
- 7.2.4.4.1.1. By Value
- 7.2.4.4.2. Market Share & Forecast
- 7.2.4.4.2.1. By Product
- 7.2.4.4.2.2. By Application
- 7.2.4.4.2.3. By End User
- 7.2.4.5. Spain Cardiopulmonary Stress Testing System Market Outlook
- 7.2.4.5.1. Market Size & Forecast
- 7.2.4.5.1.1. By Value
- 7.2.4.5.2. Market Share & Forecast
- 7.2.4.5.2.1. By Product
- 7.2.4.5.2.2. By Application
- 7.2.4.5.2.3. By End User
8. Asia Pacific Cardiopulmonary Stress Testing System Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
- 8.2.4.1. China Cardiopulmonary Stress Testing System Market Outlook
- 8.2.4.1.1. Market Size & Forecast
- 8.2.4.1.1.1. By Value
- 8.2.4.1.2. Market Share & Forecast
- 8.2.4.1.2.1. By Product
- 8.2.4.1.2.2. By Application
- 8.2.4.1.2.3. By End User
- 8.2.4.2. India Cardiopulmonary Stress Testing System Market Outlook
- 8.2.4.2.1. Market Size & Forecast
- 8.2.4.2.1.1. By Value
- 8.2.4.2.2. Market Share & Forecast
- 8.2.4.2.2.1. By Product
- 8.2.4.2.2.2. By Application
- 8.2.4.2.2.3. By End User
- 8.2.4.3. South Korea Cardiopulmonary Stress Testing System Market Outlook
- 8.2.4.3.1. Market Size & Forecast
- 8.2.4.3.1.1. By Value
- 8.2.4.3.2. Market Share & Forecast
- 8.2.4.3.2.1. By Product
- 8.2.4.3.2.2. By Application
- 8.2.4.3.2.3. By End User
- 8.2.4.4. Japan Cardiopulmonary Stress Testing System Market Outlook
- 8.2.4.4.1. Market Size & Forecast
- 8.2.4.4.1.1. By Value
- 8.2.4.4.2. Market Share & Forecast
- 8.2.4.4.2.1. By Product
- 8.2.4.4.2.2. By Application
- 8.2.4.4.2.3. By End User
- 8.2.4.5. Australia Cardiopulmonary Stress Testing System Market Outlook
- 8.2.4.5.1. Market Size & Forecast
- 8.2.4.5.1.1. By Value
- 8.2.4.5.2. Market Share & Forecast
- 8.2.4.5.2.1. By Product
- 8.2.4.5.2.2. By Application
- 8.2.4.5.2.3. By End User
9. South America Cardiopulmonary Stress Testing System Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
- 9.2.4.1. Brazil Cardiopulmonary Stress Testing System Market Outlook
- 9.2.4.1.1. Market Size & Forecast
- 9.2.4.1.1.1. By Value
- 9.2.4.1.2. Market Share & Forecast
- 9.2.4.1.2.1. By Product
- 9.2.4.1.2.2. By Application
- 9.2.4.1.2.3. By End User
- 9.2.4.2. Argentina Cardiopulmonary Stress Testing System Market Outlook
- 9.2.4.2.1. Market Size & Forecast
- 9.2.4.2.1.1. By Value
- 9.2.4.2.2. Market Share & Forecast
- 9.2.4.2.2.1. By Product
- 9.2.4.2.2.2. By Application
- 9.2.4.2.2.3. By End User
- 9.2.4.3. Colombia Cardiopulmonary Stress Testing System Market Outlook
- 9.2.4.3.1. Market Size & Forecast
- 9.2.4.3.1.1. By Value
- 9.2.4.3.2. Market Share & Forecast
- 9.2.4.3.2.1. By Product
- 9.2.4.3.2.2. By Application
- 9.2.4.3.2.3. By End User
10. Middle East & Africa Cardiopulmonary Stress Testing System Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
- 10.2.4.1. South Africa Cardiopulmonary Stress Testing System Market Outlook
- 10.2.4.1.1. Market Size & Forecast
- 10.2.4.1.1.1. By Value
- 10.2.4.1.2. Market Share & Forecast
- 10.2.4.1.2.1. By Product
- 10.2.4.1.2.2. By Application
- 10.2.4.1.2.3. By End User
- 10.2.4.2. Saudi Arabia Cardiopulmonary Stress Testing System Market Outlook
- 10.2.4.2.1. Market Size & Forecast
- 10.2.4.2.1.1. By Value
- 10.2.4.2.2. Market Share & Forecast
- 10.2.4.2.2.1. By Product
- 10.2.4.2.2.2. By Application
- 10.2.4.2.2.3. By End User
- 10.2.4.3. UAE Cardiopulmonary Stress Testing System Market Outlook
- 10.2.4.3.1. Market Size & Forecast
- 10.2.4.3.1.1. By Value
- 10.2.4.3.2. Market Share & Forecast
- 10.2.4.3.2.1. By Product
- 10.2.4.3.2.2. By Application
- 10.2.4.3.2.3. By End User
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
- 12.3. Technology Launches
13. Competitive Landscape
- 13.1. Koninklijke Philips NV.
- 13.1.1. Business Overview
- 13.1.2. Application Offerings
- 13.1.3. Recent Developments
- 13.1.4. Key Personnel
- 13.1.5. SWOT Analysis
- 13.2. Hillrom Services Inc.
- 13.3. General Electric Company
- 13.4. MGC Diagnostics Corporation.
- 13.5. OSI Systems Inc.
- 13.6. Schiller AG
- 13.7. NIHON KOHDEN CORPORATION
- 13.8. Vyaire Medical, Inc.
- 13.9. Halma plc (SunTech Medical, Inc.)
- 13.10. Cosmed srl
14. Strategic Recommendations
15. About us & Disclaimer
